Autologous dendritoma vaccine

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAutologous dendritoma vaccine

Drug Alias NameMelaxin

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesOncolix Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOncolix Inc

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A